PT1135161E - Composicao e metodo terapeutico - Google Patents

Composicao e metodo terapeutico

Info

Publication number
PT1135161E
PT1135161E PT99957794T PT99957794T PT1135161E PT 1135161 E PT1135161 E PT 1135161E PT 99957794 T PT99957794 T PT 99957794T PT 99957794 T PT99957794 T PT 99957794T PT 1135161 E PT1135161 E PT 1135161E
Authority
PT
Portugal
Prior art keywords
dna
cancer cells
phlei
composition
mcc
Prior art date
Application number
PT99957794T
Other languages
English (en)
Inventor
Nigel C Phillips
Mario C Filion
Original Assignee
Bioniche Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc filed Critical Bioniche Life Sciences Inc
Publication of PT1135161E publication Critical patent/PT1135161E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99957794T 1998-12-04 1999-12-03 Composicao e metodo terapeutico PT1135161E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11101998P 1998-12-04 1998-12-04
US12732099P 1999-04-01 1999-04-01

Publications (1)

Publication Number Publication Date
PT1135161E true PT1135161E (pt) 2005-01-31

Family

ID=26808584

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99957794T PT1135161E (pt) 1998-12-04 1999-12-03 Composicao e metodo terapeutico

Country Status (11)

Country Link
EP (1) EP1135161B1 (pt)
JP (1) JP4380922B2 (pt)
AT (1) ATE276766T1 (pt)
AU (1) AU782335B2 (pt)
CA (1) CA2353905C (pt)
DE (1) DE69920506T2 (pt)
DK (1) DK1135161T3 (pt)
ES (1) ES2229792T3 (pt)
NZ (1) NZ511941A (pt)
PT (1) PT1135161E (pt)
WO (1) WO2000033875A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794368B1 (en) 1999-04-01 2004-09-21 Bioniche Life Sciences Inc. Composition and method for inducing apoptosis in prostate cancer cells
DK1250152T3 (da) 1999-12-28 2013-08-26 Bioniche Urology Ip Inc Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
US9044422B2 (en) * 2010-10-13 2015-06-02 Bioniche Urology Ip Inc. Bacterial ribonucleic acid cell wall compositions and methods of making and using them

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4335435B2 (ja) * 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法

Also Published As

Publication number Publication date
EP1135161B1 (en) 2004-09-22
ATE276766T1 (de) 2004-10-15
WO2000033875A1 (en) 2000-06-15
DE69920506D1 (de) 2004-10-28
JP2002531524A (ja) 2002-09-24
JP4380922B2 (ja) 2009-12-09
AU1541200A (en) 2000-06-26
DK1135161T3 (da) 2005-01-24
AU782335B2 (en) 2005-07-21
CA2353905A1 (en) 2000-06-15
CA2353905C (en) 2010-06-22
ES2229792T3 (es) 2005-04-16
DE69920506T2 (de) 2005-10-13
EP1135161A1 (en) 2001-09-26
NZ511941A (en) 2003-04-29

Similar Documents

Publication Publication Date Title
NO983429L (no) Anvendelse av et texaphyrin til fremstilling av et medikament for anvendelse med et kjemoterapeutisk middel i kreftkjemosensitivisering
FR2709309B1 (fr) Compositions cellulaires, préparation et utilisations thérapeutiques.
MX368013B (es) Tratamiento de cáncer.
ES2185378T3 (es) Quimioterapia de cancer con acetildinalina en combinacion con gemcitabina, capecitabina o cisplatina.
DK1030670T3 (da) Anvendelse af vitamin D-derivater til forstærkning af virkningen af cytotoksiske midler
ATE312080T1 (de) 2-chinolonen enthaltende arzneimittel
NO993654L (no) Kit for Õ inhibere cancervekst, omfattende et kjemoterapeutisk middel og et benzimidazol og eventuelt en forsterker
TR200100054T2 (tr) Paroksetin metansülfonat
TR199701147T1 (xx) Kanserlerin geli�mesini �nlemeye mahsus, benzimidazol i�eren bir farmas�tik bile�im.
GR1003530B (el) Ταχεως διαλυομενες συνθεσεις εχουσες αναλγητικη δραση
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
WO2002030465A3 (en) Compositions that inhibit proliferation of cancer cells
ATE245655T1 (de) Organische-arsenverbindungen
PT837684E (pt) Composicoes farmaceuticas a base de um sal de diclofenac e de tiocolchicosido
TR200101547T2 (tr) Askomisinleri içeren topik kompozisyonlar
TR200503846T2 (tr) Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı
DE59911734D1 (de) Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
PT1135161E (pt) Composicao e metodo terapeutico
EP1453525A4 (en) SELECTIVE TARGETING OF APOPTIC CELLS
NO20012027D0 (no) Fremgangsmåter og blandinger for selektiv kreft-kjemoterapi
AU4391199A (en) Antioxidant, cytostatic and sustained energy composition which ameliorates the metabolic utilization of glucose
MY117808A (en) Cancer cell nuclease activator
IL143012A0 (en) Pharmaceutical composition comprising an anti-cancer agent and at least one peptide
DK1054680T3 (da) Behandling af blærecancer med mycobacterium phlei cellevæg
DK0930877T3 (da) D-methionin til formindskelse af toksiciteten af platinholdige antitumorforbindelser